(Agilent Technologies: Santa Clara, CA) -- Agilent Technologies Inc. has introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and automated applications. The new device includes an improved design that minimizes variability and improves results. Dissolution is a technique used in the pharmaceutical industry to determine the rate at which pure active pharmaceutical ingredients dissolve.

“Agilent is committed to maintaining Varian’s tradition of excellence in dissolution and establishing a new standard for pharmaceutical companies and other firms operating in a global marketplace,” says Frank Riba, Agilent business manager of Dissolution Division. “The new 708-DS Dissolution Apparatus yields the sample-to-sample consistency that is critical for scientists assessing batch-to-batch performance, bioequivalency, and other characteristics of their compounds.”

 …